The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey

The readiness of the Asian research ethics... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/13-19" }, "headline": "The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A...", "datePublished": "2024-01-08T10:33:46", "dateModified": "2024-01-08T10:33:46", "author": [ { "@type": "Person", "name": "Juntra Karbwang" }, { "@type": "Person", "name": "Cristina E. Torres" }, { "@type": "Person", "name": "Arthur M. Navarro" }, { "@type": "Person", "name": "Phanthipha Wongwai" }, { "@type": "Person", "name": "Edlyn B. Jimenez" }, { "@type": "Person", "name": "Yashashri Shetty" }, { "@type": "Person", "name": "Sudha Ramalingam" }, { "@type": "Person", "name": "Paresh Koli" }, { "@type": "Person", "name": "Lisa Amir" }, { "@type": "Person", "name": "Septi Dewi Rachmawati" }, { "@type": "Person", "name": "Monalisa Waworundeng" }, { "@type": "Person", "name": "Harnawan Rizki" }, { "@type": "Person", "name": "Asyraf Syahmi Mohd Noor" }, { "@type": "Person", "name": "Prakash Ghimire" }, { "@type": "Person", "name": "Pradip Gyanwali" }, { "@type": "Person", "name": "Subhanshi Sharma" }, { "@type": "Person", "name": "Namita Ghimire" }, { "@type": "Person", "name": "Chandanie Wanigatunge" }, { "@type": "Person", "name": "Kwanchanok Yimtae" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": " Background COVID-19 is a highly challenging infectious disease. Research ethics committees (RECs) have challenges reviewing research on this new pandemic disease under a tight timeline and public pressure. This study aimed to assess RECs’ responses and review during the outbreak in seven Asian countries where the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) networks are active. Methods The online survey was conducted in seven Asian countries from April to August 2021. Two sets of online questionnaires were developed, one set for the chairs/secretaries and another set for the REC members. The REC profiles obtained from the REC members are descriptive in nature. Data from the chairs/secretaries were compared between the RECs with external quality assessment (SIDCER-Recognized RECs, SR-RECs) and non-external quality assessment (Non-SIDCER-Recognized RECs, NSR-RECs) and analyzed using a Chi-squared test. Results A total of 688 REC members and 197 REC chairs/secretaries participated in the survey. Most RECs have standard operating procedures (SOPs), and have experience in reviewing all types of protocols, but 18.1% had no experience reviewing COVID-19 protocols. Most REC members need specific training on reviewing COVID-19 protocols (93%). In response to the outbreak, RECs used online reviews, increased meeting frequency and single/central REC. All SR-RECs had a member composition as required by the World Health Organisation ethics guidelines, while some NSR-RECs lacked non-affiliated and/or layperson members. SR-RECs reviewed more COVID-related product development protocols and indicated challenges in reviewing risk/benefit and vulnerability (0.010), informed consent form (0.002), and privacy and confidentiality (P = 0.020) than NSR-RECs. Conclusions Surveyed RECs had a general knowledge of REC operation and played a significant role in reviewing COVID-19-related product development protocols. Having active networks of RECs across regions to share updated information and resources could be one of the strategies to promote readiness for future public health emergencies. " } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/13-19/v1", "name": "The readiness of the Asian research ethics committees in responding..." } } ] } Home Browse The readiness of the Asian research ethics committees in responding... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Karbwang J, Torres CE, Navarro AM et al. The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] . F1000Research 2024, 13 :19 ( https://doi.org/10.12688/f1000research.143138.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Research Article The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] Juntra Karbwang https://orcid.org/0000-0003-2107-7173 1,2 , Cristina E. Torres 3,4 , Arthur M. Navarro 4,5 , [...] Phanthipha Wongwai 4,6 , Edlyn B. Jimenez 3 , Yashashri Shetty 7 , Sudha Ramalingam 8 , Paresh Koli https://orcid.org/0000-0002-0014-0551 7 , Lisa Amir 9,10 , Septi Dewi Rachmawati 9,11 , Monalisa Waworundeng 9,12 , Harnawan Rizki 9 , Asyraf Syahmi Mohd Noor https://orcid.org/0009-0009-1816-8120 13 , Prakash Ghimire 14 , Pradip Gyanwali 14 , Subhanshi Sharma 14 , Namita Ghimire 14 , Chandanie Wanigatunge https://orcid.org/0000-0002-4477-8979 15 , Kwanchanok Yimtae 6 Juntra Karbwang https://orcid.org/0000-0003-2107-7173 1,2 , Cristina E. Torres 3,4 , [...] Arthur M. Navarro 4,5 , Phanthipha Wongwai 4,6 , Edlyn B. Jimenez 3 , Yashashri Shetty 7 , Sudha Ramalingam 8 , Paresh Koli https://orcid.org/0000-0002-0014-0551 7 , Lisa Amir 9,10 , Septi Dewi Rachmawati 9,11 , Monalisa Waworundeng 9,12 , Harnawan Rizki 9 , Asyraf Syahmi Mohd Noor https://orcid.org/0009-0009-1816-8120 13 , Prakash Ghimire 14 , Pradip Gyanwali 14 , Subhanshi Sharma 14 , Namita Ghimire 14 , Chandanie Wanigatunge https://orcid.org/0000-0002-4477-8979 15 , Kwanchanok Yimtae 6 PUBLISHED 08 Jan 2024 Author details Author details 1 Drug Discovery and Development Center, Thammasat University, Pathum Thani, Bangkok, 12120, Thailand 2 Clinical Coordination and Training Center, Strategic Initiative in Developing Capacity in Ethical Review (SIDCER), Thammasat University, Pathum Thani, 12120, Thailand 3 National Institutes of Health, University of the Philippines Manila, Manila, Metro Manila, 1000, Philippines 4 Clinical Coordination and Training Center, Forum for Ethical Review Committees in Asia and the Pacific (FERCAP), Thammasat University, Pathum Thani, 12120, Thailand 5 Department of Social Sciences, University of the Philippines Manila, Manila, Metro Manila, 1000, Philippines 6 Faculty of Medicine, Khon Kaen University, Nai Mueang, Khon Kaen, 40002, Thailand 7 Department of Pharmacology & Therapeutics, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, 400012, India 8 Department of Community Medicine, PSG Institute of Medical Sciences and Reseach, Coimbatore, 641004, India 9 Forum of Indonesian Recognized Ethics Committees (FIRREC), Jakarta, 10430, Indonesia 10 Dental Research Ethics Committee Faculty of Dentistry, Universitas Indonesia, Jakarta, Jakarta, 10430, Indonesia 11 Health Research Ethics Committee, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia 12 Ethics Committee, Mochtar Riady Institute for Nanotechnology (MRIN), Tangerang, 15810, Indonesia 13 National Institutes of Health, Ministry of Health, Federal Government of Malaysia, Kuala Lumpur, 40170, Malaysia 14 National Ethical Review Board, Nepal Health Research Council, Ministry of Health & Population, Kathmandu, 7626, Nepal 15 Faculty of Medical Science, University of Sri Jayewardenepura, Gangodawila, Nugegoda, 10250, Sri Lanka Juntra Karbwang Roles: Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Validation, Writing – Original Draft Preparation, Writing – Review & Editing Cristina E. Torres Roles: Conceptualization, Investigation, Methodology, Project Administration, Validation, Writing – Review & Editing Arthur M. Navarro Roles: Formal Analysis, Investigation, Software, Validation, Writing – Review & Editing Phanthipha Wongwai Roles: Data Curation, Investigation, Project Administration, Supervision, Validation, Visualization, Writing – Review & Editing Edlyn B. Jimenez Roles: Data Curation, Investigation, Methodology, Supervision, Validation, Writing – Review & Editing Yashashri Shetty Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Sudha Ramalingam Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Paresh Koli Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Lisa Amir Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Septi Dewi Rachmawati Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Monalisa Waworundeng Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Harnawan Rizki Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Asyraf Syahmi Mohd Noor Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Prakash Ghimire Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Pradip Gyanwali Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Subhanshi Sharma Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Namita Ghimire Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Chandanie Wanigatunge Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Kwanchanok Yimtae Roles: Data Curation, Investigation, Project Administration, Supervision, Validation, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS This article is included in the TDR gateway. Abstract Background COVID-19 is a highly challenging infectious disease. Research ethics committees (RECs) have challenges reviewing research on this new pandemic disease under a tight timeline and public pressure. This study aimed to assess RECs’ responses and review during the outbreak in seven Asian countries where the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) networks are active. Methods The online survey was conducted in seven Asian countries from April to August 2021. Two sets of online questionnaires were developed, one set for the chairs/secretaries and another set for the REC members. The REC profiles obtained from the REC members are descriptive in nature. Data from the chairs/secretaries were compared between the RECs with external quality assessment (SIDCER-Recognized RECs, SR-RECs) and non-external quality assessment (Non-SIDCER-Recognized RECs, NSR-RECs) and analyzed using a Chi-squared test. Results A total of 688 REC members and 197 REC chairs/secretaries participated in the survey. Most RECs have standard operating procedures (SOPs), and have experience in reviewing all types of protocols, but 18.1% had no experience reviewing COVID-19 protocols. Most REC members need specific training on reviewing COVID-19 protocols (93%). In response to the outbreak, RECs used online reviews, increased meeting frequency and single/central REC. All SR-RECs had a member composition as required by the World Health Organisation ethics guidelines, while some NSR-RECs lacked non-affiliated and/or layperson members. SR-RECs reviewed more COVID-related product development protocols and indicated challenges in reviewing risk/benefit and vulnerability (0.010), informed consent form (0.002), and privacy and confidentiality (P = 0.020) than NSR-RECs. Conclusions Surveyed RECs had a general knowledge of REC operation and played a significant role in reviewing COVID-19-related product development protocols. Having active networks of RECs across regions to share updated information and resources could be one of the strategies to promote readiness for future public health emergencies. READ ALL READ LESS Keywords COVID-19, Pandemic, IRB, Institutional review board, research ethics committee, Strategic Initiative for Developing Capacity in Ethical Review, SIDCER, Network Corresponding Author(s) Juntra Karbwang ( [email protected] ) Close Corresponding author: Juntra Karbwang Competing interests: No competing interests were disclosed. Grant information: This work was supported by the TDR Strategic Development Fund, the Special Programme for Research and Training in Tropical Diseases co-sponsored by UNICEF, United Nations Development Program, World Bank and World Health Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2024 Karbwang J et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Karbwang J, Torres CE, Navarro AM et al. The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] . F1000Research 2024, 13 :19 ( https://doi.org/10.12688/f1000research.143138.1 ) First published: 08 Jan 2024, 13 :19 ( https://doi.org/10.12688/f1000research.143138.1 ) Latest published: 08 Jan 2024, 13 :19 ( https://doi.org/10.12688/f1000research.143138.1 ) Introduction COVID-19 is a new, highly infectious disease that seriously challenges the research community. 1 , 2 There are limited effective drugs and vaccines available and, to date, very limited specific treatment for mild COVID-19, which accounts for 80% of COVID-19 infected patients. 3 , 4 Research on new treatments, prophylactics, and diagnostic products to address disease outbreaks is needed. 3 , 5 Under the limited supply of effective drugs and vaccines, flattening the curve of the infection depends on adherence to the public health socio-behavioural interventions imposed by the state. 6 , 7 Research on the effectiveness and acceptability of these non-pharmaceutical interventions is important to assist in making the decision about how to address the outbreak. 8 , 9 While the researchers are finding solutions to end the epidemic, the institutional review boards (IRBs)/research ethics committees (RECs) are responsible for the oversight of research conduct to ensure that the researchers adhere to scientific principles and uphold the ethical principles of autonomy, beneficence, and justice and that they are responsive to the COVID-19 outbreak. 10 Local IRBs/RECs have to encounter new challenges, some related to research approval of new investigational tools and approaches against the pandemic under a tight timeline and public pressure, 1 , 2 and others related to delays in ongoing activities due to the diversion of human resources towards the pandemic response. 11 Some local RECs in different countries may not be ready to address the challenges arising from the COVID-19 pandemic. 12 The present study aimed to find the RECs’ responses and review practices during the COVID-19 outbreak in Asian countries, where Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) networks are active in training and quality evaluation of RECs ( www.SIDCER-FERCAP.org ). This study describes how the local RECs in Asian countries faced and addressed the challenges in ethics review during the COVID-19 outbreak. Specifically, the study assessed RECs’ operational readiness and challenges to conduct the ethics review during the COVID-19 pandemic. Methods A multi-center cross-sectional, descriptive survey was conducted in seven countries by local team members of the Forum for Ethical Review Committees in the Asian and Western Pacific Region (FERCAP) network. The survey was carried out from April to August 2021. FERCAP conducted a common online survey of RECs in Asia among the RECs with external quality assessment (SIDCER recognized REC (SR-REC)) and no external quality assessment (Non-SIDCER recognized REC (NSR-REC)) to determine the response and review practices of RECs during the COVID-19 outbreak. Study materials Two sets of questionnaires were developed using online Google forms, one set for the chairs/secretaries, and another set for the members. The questionnaires for the chairs/secretaries focused on REC profiles, activities during the COVID-19 outbreak, and identification of training needs among SR-RECs and NSR-RECs. The questionnaires to be completed by members gathered information on the REC’s membership profile, number of protocols reviewed, challenges encountered during COVID-19, training needs, and their knowledge and attitudes about reviewing COVID-19 related research. Knowledge and attitude questions were also prepared on five Likert scales. The initial draft questionnaire was pretested by sending it to focal persons in each country to determine if there was a common understanding of the questions and the expected response. Several meetings were held to discuss and share specific country issues related to the survey instrument and the target population, and the protocol was revised accordingly. No reliability test was done. Study populations and sample size determination The study enrolled REC chairs/secretaries and members in seven countries: India, Indonesia, Malaysia, Nepal, Philippines, Sri Lanka, and Thailand. The current project utilized the resources and infrastructure of the existing networks (FERCAP and local ethics networks of each country). FERCAP gathered information from RECs that are network members and from other RECs who would agree to respond to the survey. FERCAP targeted a purposive sample of 500 REC members. The recruitment was conducted from April to August 2021. Study procedure and data collection A round of meetings was held among the involved team members to finalize the protocol and share the protocol along with the set of questionnaires and informed consent forms in the online Google form. After getting the approval from the REC, the selected chair/secretaries and the members were sent the Google form for their response. Ethical consideration The study protocol was reviewed and approved by local RECs and some RECs granted exemption or subjected it to expedited review before the conduct of the survey in each country: Khon Kaen University Ethics Committee, Thailand, dated 31 March 2021 (HE641148); Republic of the Philippines, Department of health, Manila, Philippines, Single joint research ethics board, 1 June 2021 (SJREB-2021-40); Nepal Health Research Council, 24 March 2021 (190/2021P); Ethic Review committee Sri Lanka Medical Association, 21 May 2021 (ERC 21-010); Seth GS Medical College and KEM Hospital, Mumbai, India, 15 June 2021 (IEC (II)/OUT/427/2021); National Institute of Health (NIH), Malaysia, Medical research & Ethic Committee, 2 June 2021 (NMRR-21-969-59930 (IIR)); Faculty of Dentistry, University of Indonesia, Dental Research Ethics Committee, 5 April 2021 (01 Ethical exempted/FKGUI/IV/2021). 13 Written informed consent was obtained through voluntary action by answering the Google form questionnaire in English. The answers from the REC chairs/secretaries were identifiable. However, in the case of REC members, answers were anonymous. Data analysis The collected data were analyzed to identify the common trends, significant challenges, and solutions. The information obtained from the REC members was described and presented in bar/pie/stacked charts. The data for the knowledge and attitude of REC members were presented in the stacked chart as a percentage of each value from the Likert scale; the data were also analyzed to obtain the means (SD) and interquartile range. The data from the chairs/secretaries were compared between SR-RECs and NSR-RECs presented in percentages and analyzed using the Chi-squared test in SPSS version 22. Results The questionnaires were sent to 332 RECs, and the total responses from the chair/secretaries were 197 (59.3%), with 688 responses from the REC members ( Table 1 ). Table 1. Number of research ethics committee (REC) questionnaires sent and responses from REC chairs/secretaries and members. Country REC questionnaires sent (n) REC chair/secretary responded (n) % of REC responded REC members responded (n) India 40 25 (11/14) 62.5% 84 Indonesia 14 11 78.6% 100 Malaysia 15 10 66.7% 84 Nepal 52 48 92.3% 108 Philippines 79 54 68.4% 125 Sri Lanka 10 10 100% 79 Thailand 122 39 32% 108 Total 332 197 59.3% 688 Information from REC members survey Fifty-one percent of the participants came from academic research institutions, followed by 33% from hospitals (Underlying data: Supplementary Figure 1 13 ). The majority of participants were medical doctors/dentists, followed by other medical professionals such as nurses, pharmacists, etc. (Underlying data: Supplementary Figure 2 13 ). There were equal numbers of social and biomedical scientists (7%), and a few laypersons and lawyers (6% and 3%, respectively). Most members reviewed only scientific/technical issues and less than 20% of members reviewed only Informed Consent Forms (ICFs); however, 8.9% claimed that they reviewed both technical and ICF issues (Underlying data: Supplementary Figure 3 13 ). Standard operating procedures (SOPs) All of the countries have standard operating procedures (SOPs) but not all RECs in Sri Lanka had SOPs (Eight participants reported no SOPs) (Underlying data: Supplementary Figure 4 13 ). Within those RECs that reported having SOPs, there was a lack of some standard procedures. A total of 12.5% of participants indicated no SOP on structure and composition, 11.8% on initial review, 19.1% on post-approval process and documentation, 19.7% on standard assessment, 18.1% on agenda and minutes, 30.6% on serious adverse events (SAE) review, and 30.6% on archiving. A total of 31.8% of participants indicated that the list of international and national guidelines was missing. Frequency of meeting (N = 681) Most RECs had monthly board meetings (65.2%), followed by every two weeks (12.2%), and every week (7.6%) (except Sri Lanka), 9.1% quarterly, 2.5% every semester (except Sri Lanka), 1.0% annually (only in Malaysia and India). Only 2.3% had no REC meetings (only in Malaysia) (Underlying data: Supplementary Figure 5 13 ). Participation of members in a different type of protocol review as part of their regular review function Generally, members from all countries (N = 678) have experience in reviewing all types of protocol (Underlying data: Supplementary Figure 6 13 ) but were most familiar with clinical research (79.9%) followed by public health (72.6%), socio-behavioural research (61.1%) and laboratory research (50.0%). One hundred and twenty-four participants (18.1%) indicated that they had not been reviewing COVID-19 protocols. Generally, when reviewing COVID-19 protocols, members reviewed all elements required by international standards except advertisements, where half (50.6%) of the participants indicated that they had not reviewed this element (Underlying data: Supplementary Figure 7 13 ). Challenges when reviewing COVID-19 protocols For those members who reviewed COVID-19 protocols (N = 503), several challenges were identified with the top three being the review of risk/benefit (46.1%), scientific design (35.6%), and vulnerability 34.6%. However, one-third (29.2%) of participants reported that they had no difficulty in reviewing COVID-19 protocols (Underlying data: Supplementary Figure 8 13 ). Training needs A total of 87.0% of participants (N = 684) indicated the need for training when reviewing COVID-19 protocols. The top three training needs (identified from 678 participants) were ethical issues relating to clinical research (60.9%), risk/benefit assessment (57.1%), and international guidelines and regulations (55.0%) (Underlying data: Supplementary Figure 9 13 ). Perspectives of REC members on the operation of RECs during the COVID-19 outbreak Regarding the review of COVID-19 protocols, most of the participants conducted an online full board meeting (94.1%) and used a joint or central REC review in the case of a multi-centred study (92.1%). The participants also agreed that RECs need training in ethics review of COVID-19 protocols (93%). The participants considered that the majority of COVID-19 protocols were high risk and should be reviewed by the full board. The majority of participants recognized the issues of confidentiality and conflicts of interest (CoI) involving COVID-19 protocols (91.1%) and the importance of addressing these issues ( Figure 1 ). Figure 1. The perspectives of members on the operation of research ethics committees using a Likert Scale. Knowledge of REC members Figure 1 demonstrates that more than 90% of the participants agreed that COVID-19 patients were vulnerable. They also agreed on the need for RECs to review and approve studies related to traditional medicine (82.2%), or unproven drugs, vaccines, and interventions for COVID-19 (85.1%). More than half of the participants thought that COVID-19 patients in hospitals should be allowed to participate in clinical trials. More than half of the participants were against employees of drug companies acting as principal investigators in Phase III clinical trials. There were controversial opinions on three items with regard to COVID-19 studies 1 : The principal investigator can be any medical doctor, 2 Any REC medical doctor can review technical issues, and 3 Only COVID-19 patients should sign the ICFs ( Figures 1 and 2 ). Figure 2. Perspectives of research ethics committee members towards COVID-19 protocol review. SIDCER-recognized (SR) and non-SIDCER-recognized (NSR) RECs: Information obtained from chairs/secretaries During the COVID-19 outbreak, similar measures were implemented in both SR-RECs and NSR-RECs surveyed such as masks, social distancing, community lockdown, travel restrictions, and limited access to institution facilities. The only difference between the SR-RECs and NSR-RECs was the limited access to institution facilities, which was found to be higher in SR-RECs (P = 0.03). Composition of RECs SR-RECs complied with the member composition of RECs as required by the regulatory requirements and international guidelines, while some of the NSR-RECs lack non-affiliated and lay members. This aspect was significantly different between SR-RECs and NSR-RECs (P = 0.000 and 0.000, respectively) ( Figure 3 ). Figure 3. Composition of research ethics committees. Protocol review: REC meeting, the workload of the RECs, type of protocol review, and post-approval review Both SR-RECs and NSR-RECs had adopted online meetings (80% and 66%, respectively). Some used online and face-to-face meetings (15% and 24%, respectively), and a few used face-to-face meetings only (5% and 10%, respectively). Figure 4 shows the workload of RECs, type of protocol reviewed, and post-approval review. More NSR-RECs reviewed less than 100 protocols during 2020 (P = 0.004) while more SR-RECs reviewed more than 500 protocols during 2020 (P < 0.004). Figure 4. Number and type of protocol reviewed. Both SR-RECs and NSR-RECs reviewed social and community, public health, and product development protocols. All countries reviewed COVID-19 protocols; however, some RECs did not review COVID-19 protocols (6 SR-RECs and 25 NSR-RECs). Significantly more SR-RECs reviewed COVID-19 protocols (P = 0.003) and product development protocols i.e. drug, vaccine, and diagnostic protocols (P = 0.000). Both SR-RECs and NSR-RECs reviewed post-approval protocols. However, more SR-RECs reported having reviewed protocol violations (P = 0.001). Challenges in reviewing COVID-19 protocols Although both SR-RECs and NSR-RECs identified challenges in the review of the scientific methodology, ethical issue, ICF, CoI, and privacy and confidential issues ( Figure 5 ), more SR-RECs identified challenges in the review of risk/benefit and vulnerability (0.010), ICF (0.002), and privacy and confidentiality issues (P = 0.020). Figure 5. Challenges identified by research ethics committee chairs/secretaries in reviewing COVID-19 protocols. Training needs for reviewing COVID-19 protocols Similar training needs demanded by the chairs/secretaries of SR-RECs and NSR-RECs are shown in Figure 6 . However, the need for training on specific ethical issues related to clinical trials was found to be significantly higher in SR-RECs when compared with NSR-RECs (P = 0.001). Figure 6. Training recommended by research ethics committee chairs and secretaries. Discussion The composition of Asian RECs The results from the survey suggested that the RECs in Asian countries generally had satisfactory membership requirements including a multidisciplinary composition as required by international guidelines such as those provided by WHO, 14 the Council for International Organizations of Medical Sciences (CIOMS), 15 and The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Good Clinical Practice (ICH GCP). 16 The members of these RECs are typically composed of medical doctors/dentists, nurses, pharmacists, biomedical researchers, lawyers, bio-statisticians, social scientists, non-affiliated and laypersons. However, it was noted that some RECs lack laypersons and/or non-affiliated members. The WHO guidelines emphasize the importance of including laypersons in RECs, as they play a vital role in representing the insights and perspectives of research participants. Additionally, the guidelines highlight the inclusion of non-affiliated members to enhance the independence of the committee. The absence of laypersons and/or non-affiliated members in some RECs may compromise their functionality and not align with the WHO guidelines and the European Medicines Agency (EMA) requirements, which mandate at least one lay and one non-affiliated member. 14 , 17 The lack of explicit requirements for a layperson in some guidelines such as ICH GCP, may contribute to the absence of laypersons in certain committees. While the ICH GCP only calls for a “non-scientific member”, it is important to note that not all non-scientific members necessarily fulfil the role of a layperson who can effectively represent the perspectives of patients or research participants. 14 When comparing the composition of SR-RECs and NSR-RECs, it was found that SR-RECs comply better with international membership requirements by having laypersons and non-affiliated members. Including laypersons and non-affiliated members is crucial to ensure that the voices and perspectives of research participants are considered during the review process and that the decision-making process maintains independence. 14 The RECs’ response to the COVID-19 pandemic The Asian RECs adjusted well to the restrictions imposed by the government during the COVID-19 pandemic by utilizing online meeting platforms that also enabled them to prioritize the review of COVID-19 protocols by holding more frequent meetings as recommended by WHO as part of the pandemic response. 18 To streamline the review process for multi-center COVID-19 protocols and other types of research, most of the REC members in this survey agreed to the use of a joint or single review system. Implementing a joint/single/central REC model was facilitated in Asia due to the harmonization of SOPs among 275 RECs certified under the SIDCER Recognition Program. 19 This program fostered trust among SR RECs, enabling them to rely on using joint or single or central REC arrangements during the COVID-19 outbreak. This helped ensure the quality and timely review of multi-center clinical trials. 18 It is worth noting that other countries faced challenges in the rapid review of multi-site COVID-19 protocols. South Africa, for example, encountered difficulties related to the operational readiness of their RECs. 20 In the United States, using a single IRB has become mandatory for multi-center studies as part of the US Common Rule, aiming to ensure timely review of such studies. 21 Overall, the adoption of online platforms, more frequent meetings, and the practice of joint or single review systems have been effective strategies employed by Asian RECs to address the challenges posed by the COVID-19 pandemic and timely review of multi-center research protocols. The ability of RECs to identify general ethical issues involving COVID-19 protocols In general, the RECs in Asia can identify ethical issues in COVID-19 protocols. Most of the REC members classified the COVID-19 protocols as a high-risk type of research due to many uncertainties about the disease, and the vulnerability of the population in low- and middle-income countries. Despite recognizing the vulnerability of COVID-19 patients, REC members agreed that these patients should be included in clinical trials, demonstrating their familiarity with ethical principles outlined in guidelines such as the CIOMS ethical guidelines, which recommend the inclusion of vulnerable participants in health research unless there is a scientific justification for their exclusion. 22 – 25 More than half of REC members disagreed that drug company employees should be principal investigator in Phase III clinical trials ( Figure 2 ) indicating their recognition of CoI and the need to manage such conflict. 26 Furthermore, research on off-label use of herbal medicine such as andrographolide or repurposed drugs like hydroxychloroquine or ivermectin was common during the pandemic. 27 , 28 In this survey, many REC Members agreed that the use of herbal medicine and off-label drugs should undergo clinical trials subject to REC review to gather evidence on their safety and efficacy for COVID-19. It was acknowledged that the dose and usage of these substances may differ from their established indications, which could lead to adverse side effects. 29 – 31 The regular RECs training provided by the SIDCER network, which was established by the WHO special program in Tropical Disease Research (TDR) in 2001, has significantly contributed to the capacity-building of these RECs in Asia regardless of whether they were NSR-RECs or SR-RECs. The SIDCER network conducts regular research ethics training in FERCAP member countries in collaboration with local country fora in the Philippines, Indonesia, India, Sri Lanka, Malaysia, Nepal, Taiwan, and Thailand. 19 This demonstrates the importance of active networks of RECs across regions for sharing information, resources, and expertise, and it serves as a strategy to enhance readiness for future public health emergencies. Overall, the efforts to strengthen REC capacity through training and networking have been instrumental in ensuring that ethical considerations are addressed effectively in COVID-19 research in Asia. Requirement of post-approval review The important responsibilities of RECs are to scrutinize scientific soundness in research protocols that seek to generate new information and novel interventions to control the pandemic and ensure that the researchers uphold ethical principles to protect human participants. 26 In addition to the initial review and approval of research protocols, RECs are responsible for monitoring researcher compliance with the approved protocols. This includes reviewing remote patient monitoring reports submitted by research teams and ensuring that researchers are updated about changes in prevention and treatment guidelines as new COVID-19 variants emerge. Post-approval review is essential to ensure the ongoing benefit and safety of research participants. While both SR-RECs and NSR-RECs reported conducting post-approval reviews, it was found that SR-RECs had more experience in reviewing protocol violations. This may be attributed to the fact that SR-RECs have undergone assessment regularly through the SIDCER Recognition Program, which includes evaluation of the REC’s post-approval monitoring process. This recognition process provides assurance that SR RECs have robust post-monitoring activities in place. Additionally, SR-RECs often review more product development protocols, especially those supported by pharmaceutical companies. In these cases, there is typically better monitoring of GCP compliance as part of the sponsor’s responsibility; as a rule, the sponsor ensures that the investigators report all deviations/violations to the RECs for review. 16 The RECs call for training on specific COVID-19 issues Although both SR-RECs and NSR-RECs identified issues encountered with COVID-19, they still expressed the need for further training to effectively analyze and address the unique ethical challenges presented by COVID-19 protocols. The pandemic introduced specific ethical issues that were not encountered before 32 – 35 and therefore additional training is crucial to ensure the scientific and ethical validity of research. COVID-19 was a novel disease that spread rapidly and had severe health consequences, including death and serious health conditions. The uncertainty surrounding its origin, transmission, and evolution, combined with the limited availability of treatment and prevention options, posed significant challenges for the scientific community. Researchers and scientists were under pressure to conduct research and find rapid solutions to contain the spread of the virus and mitigate its impact. 36 , 37 While the urgency of the situation called for expedited research, it was crucial that COVID-19 research adhered to scientific standards and ethical compliance. New ethical challenges arose due to the public health emergency environment, where authorities imposed the movement restrictions. COVID-19 patients were quarantined at home or in hospitals, and some were in intensive care, making it more difficult to obtain informed consent using traditional practices. 33 , 34 , 38 , 39 To adapt to these challenges, RECs faced the task of approving various forms of informed consent, including electronic consent, telephone consent, consent obtained through legally acceptable representatives, oral consent, waivers of signature, and other mechanisms that ensured consent was truly obtained, as required by the RECs. 34 , 39 To navigate these challenges and ensure that research is conducted with scientific and ethical integrity, REC members require specific training. This training can cover various aspects, such as updates on evolving guidelines and regulations, and enhancing skills in analyzing complex study designs and methodologies. By providing REC members with targeted training, they can gain the necessary knowledge and tools to effectively assess and address the ethical challenges specific to COVID-19 research. This training helps to promote consistency, rigor, and ethical compliance during the review process, ultimately safeguarding the rights, welfare, and well-being of research participants. Challenges in reviewing COVID-19 protocols The REC members indicated that study design was one of the top challenges in reviewing COVID-19 protocols. In other studies, study design has also been raised as one of the challenges in COVID-19 reviews. 33 , 34 , 40 Adaptive design has been introduced in many COVID-19 clinical trials to enhance the speed of product development. Although the advantages of the adaptive design have been accepted in many scientific communities, it was difficult for RECs to review them as risk/benefit ratio changed when methods, data analysis and products were modified during the course of a study. 41 , 42 To address these challenges, REC members must familiarize themselves with different study designs, particularly adaptive design. By gaining knowledge and understanding of various study designs, RECs can be better prepared for future epidemics or public health emergencies where quick identification of new treatments is crucial to combat the disease outbreak. Although both SR-RECs and NSR-RECs identified several challenges in the review of protocols during the pandemic, SR-RECs are better equipped than NSR-RECs in reviewing COVID-19 and investigational medicinal product development protocols. One contributing factor is that SR-RECs have undergone assessment regularly through the SIDCER recognition program. 19 The program evaluates various aspects of the REC’s review practice. The assessment includes the appropriateness of the composition of the REC, its operational procedures, and the thoroughness and completeness of the scientific and ethical review protocols. The program ensures that SR-RECs adhere to international ethical guidelines and the ICH GCP in their composition, operation and review processes. By undergoing this assessment, SR-RECs have proven their commitment to maintaining high scientific and ethical review standards. They have demonstrated their capability to effectively manage the review of COVID-19 and investigational product development studies comprehensively and rigorously. This recognition program helps enhance the capacity of SR-RECs and instills confidence in their ability to conduct ethical reviews of research protocols related to public health emergencies like COVID-19. Limitation of the study Most of the participants who responded to the questionnaires were in the medical field and thus may not adequately represent the perspectives of the non-medical REC members. The number of participants was not equal for each country, as well as the SR-RECs and NSR-RECs. The questionnaires were in English thus some participants may not exactly understand the questions and skipped some questions. Conclusions The COVID-19 pandemic created an opportunity to highlight the importance of competent RECs that developed with the assistance of existing local research ethics networks under SIDCER-FERCAP in Asia. The Asian RECs responded to the challenges of the COVID-19 outbreak by adopting online platforms, more frequent meetings, and the use of joint or single review systems to ensure timely review. During the COVID-19 outbreak, RECs in countries with SIDCER networks generally had a basic understanding of REC operations and ethical principles when reviewing protocols related to the pandemic. However, specific training may have been necessary to enhance the quality of their reviews. The SR-RECs played a significant role in reviewing COVID-19 protocols, including those related to product development. These RECs effectively managed the unique challenges posed by the pandemic while conducting ethics reviews. To further strengthen the capacity for future public health emergencies, one strategy is to establish and maintain active networks of ethics committees across regions. These networks facilitate the exchange of new information, resources, and best practices among RECs. By sharing knowledge and collaborating, these RECs can enhance their preparedness and readiness to respond effectively to similar public health emergencies in the future. This collaborative approach promotes harmonized procedure, consistency and high-quality ethics review, ultimately protecting the rights and welfare of research participants. Consent Implied informed consent for publication of the participants’ details was obtained from the participants. Data availability Underlying data Figshare: Underlying data for ‘The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey’, https://doi.org/10.6084/m9.figshare.24261226.v5 . 13 This project contains the following underlying data: • Data file: TDR EC survey 2020 AUG 3 2022.xlsx - Sheet 1 “EC Member”: Survey responses of participants who are REC members. - Sheet2 “COVID Review”: Isolation and processing of the REC members’ survey responses regarding the operation of the members’ respective RECs with regards to COVID-19 protocols and the perception of EC members on ethical issues of COVID-19 research. - Sheet 3 “COVID Review Chart”: Reformatted data from the “COVID Review” sheet to display the processed data as stack bar charts. - Sheet 4 “Chair”: Survey responses of participants who are REC chairs/secretaries. - Sheet 5 “Affiliation”: Isolation and processing of the REC chairs/secretaries’ survey responses regarding the institution type/affiliation of their respective RECs in order to compare the affiliations of SR-RECs versus NSR-RECs. - Sheet 6 “Chair Composition”: Isolation and processing of the REC chairs/secretaries’ survey responses regarding the respondents’ role in their respective RECs in order to compare the compositions of SR-RECs versus NSR-RECs. - Sheet 7 “# Prot Rev”: Isolation and processing of the REC chairs/secretaries’ survey responses regarding the number of protocols reviewed by the respondents’ respective RECs in order to compare the number of protocols reviewed by SR-RECs versus NSR-RECs. - Sheet 8 “Issues”: Isolation and processing of the REC chairs/secretaries’ survey responses regarding the issues reviewed by the respondents’ respective RECs in order to compare the issues reviewed by SR-RECs versus NSR-RECs. - Sheet 9 “Training”: Isolation and processing of the REC chairs/secretaries’ survey responses regarding the training needs of the respondents’ respective RECs in order to compare the training needs of SR-RECs versus NSR-RECs. • Supplementary Figure 1: Participant Distribution.jpg • Supplementary Figure 2: The Roles-Expertise of Participants in REC.jpg • Supplementary Figure 3: Review Function of Participants in REC.jpg • Supplementary Figure 4: SOPs.jpg • Supplementary Figure 5: Frequency of REC Meeting.jpg • Supplementary Figure 6: Experience of Members in Reviewing Types of Protocols.jpg • Supplementary Figure 7: Elements Reviewed by REC when Reviewing COVID Protocols.jpg • Supplementary Figure 8: Challenges Identified by REC Members in Reviewing COVID-19 Protocols.jpg • Supplementary Figure 9: Training Needs when Reviewing COVID-19 Protocols.jpg Extended data Figshare: Extended data for ‘The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey’, https://doi.org/10.6084/m9.figshare.24261226.v5 . 13 This project contains the following extended data: • IRB Covid Survey Questionnaire.pdf • EC-IRB information version 2.docx Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0) Acknowledgements We are grateful to Dr. Junjira Laothavorn for her assistance in the visualization of the data presentation. We sincerely appreciate her exceptional data visualisation skills, which have played a crucial role in transforming complex and raw data into visually appealing and informative graphical representations. We also would like to thank Dr. Panida Kongjam for her support in statistical analysis. References 1. Sisk BA, Baldwin K, Parsons M, et al. : Ethical, regulatory, and practical barriers to COVID-19 research: A stakeholder-informed inventory of concerns. PLoS One. 2022; 17 (3): e0265252. PubMed Abstract | Publisher Full Text | Free Full Text 2. Ford DE, Johnson A, Nichols JJ, et al. : Challenges and lessons learned for institutional review board procedures during the COVID-19 pandemic. J Clin Transl Sci. 2021 Mar 16; 5 (1): e107. PubMed Abstract | Publisher Full Text | Free Full Text 3. World Health Organization (WHO): Clinical management of COVID-19: Living guideline. World Health Organization (WHO); 2023 [cited 2023 May 31]. Reference Source 4. Heustess AM, Allard MA, Thompson DK, et al. : Clinical Management of COVID-19: A Review of Pharmacological Treatment Options. Pharm Basel Switz. 2021 May 28; 14 (6): 520. PubMed Abstract | Publisher Full Text | Free Full Text 5. National Institute of Allergy and Infectious Diseases: NIAID strategic Plan for COVID-19 research – 2021 Update.[cited 2023 May 20]. Reference Source 6. Lewnard JA, Lo NC: Scientific and ethical basis for social-distancing interventions against COVID-19. Lancet Infect Dis. 2020 Jun; 20 (6): 631–633. PubMed Abstract | Publisher Full Text | Free Full Text 7. Wright AL, Sonin K, Driscoll J, et al. : Poverty and economic dislocation reduce compliance with COVID-19 shelter-in-place protocols. J Econ Behav Organ. 2020 Dec; 180 : 544–554. PubMed Abstract | Publisher Full Text | Free Full Text 8. Schneiders ML, Naemiratch B, Cheah PK, et al. : The impact of COVID-19 non-pharmaceutical interventions on the lived experiences of people living in Thailand, Malaysia, Italy and the United Kingdom: A cross-country qualitative study. PLoS One. 2022; 17 (1): e0262421. PubMed Abstract | Publisher Full Text | Free Full Text 9. Teasdale E, Santer M, Geraghty AWA, et al. : Public perceptions of non-pharmaceutical interventions for reducing transmission of respiratory infection: systematic review and synthesis of qualitative studies. BMC Public Health. 2014 Jun 11; 14 : 589. PubMed Abstract | Publisher Full Text | Free Full Text 10. ISS COVID-19 Bioethics Working Group: Research ethics during the COVID-19 pandemic: observational and, in particular, epidemiological studies.2020 [cited 2023 May 20]. Reference Source 11. Hamouche S: Human resource management and the COVID-19 crisis: implications, challenges, opportunities, and future organizational directions. J Manag Organ. 2021 Apr 19; 29 : 799–814. Publisher Full Text 12. Palmero A, Carracedo S, Cabrera N, et al. : Governance frameworks for COVID-19 research ethics review and oversight in Latin America: an exploratory study. BMC Med Ethics. 2021 Nov 6; 22 (1): 147. PubMed Abstract | Publisher Full Text | Free Full Text 13. Karbwang J, Torres CE, Navarro A, et al. : The Readiness of the Asian Research Ethics Committees in Responding to the COVID-19 Pandemic Research Dataset. figshare. 2023. Publisher Full Text 14. World Health Organization (WHO): Research Ethics Review Committee.[cited 2023 May 31]. Reference Source 15. Guideline 23: Requirements for Establishing Research Ethics Committees and for Their Review of Protocols. International Ethical Guidelines for Health-related Research Involving Humans. 4th ed.Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2016; pp. 87–90. 16. Efficacy Guidelines: The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).[cited 2023 May 31]. Reference Source 17. European Medicines Agency (EMA): Scientific guidelines. European Medicines Agency (EMA); 2018 [cited 2023 May 31]. Reference Source 18. World Health Organization (WHO): Ethics and COVID-19.[cited 2023 May 31]. Reference Source 19. The SIDCER-FERCAP Foundation: [cited 2023 May 31]. Reference Source 20. Rossouw TM, Wassenaar D, Kruger M, et al. : Research ethics support during the COVID-19 epidemic: a collaborative effort by South African Research Ethics Committees.Govender K, George G, Padarath A, et al. , editors. South African Health Review 2021. Durban: Health Systems Trust; 2021; pp. 163–172. Reference Source 21. Office for Human Research Protections (OHRP): Single IRB Exception Determinations. U.S. Department of Health and Human Services; 2019 [cited 2023 May 31]. Reference Source 22. Guideline 16: Research Involving Adults Incapable of Giving Informed Consent. International Ethical Guidelines for Health-related Research Involving Humans. 4th ed.Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2016; pp. 61–64. 23. Guideline 17: Research Involving Children and Adolescents. International Ethical Guidelines for Health-related Research Involving Humans. 4th ed.Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2016; pp. 65–68. 24. Guideline 18: Women as Research Participants. International Ethical Guidelines for Health-related Research Involving Humans. 4th ed.Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2016; pp. 69–70. 25. Guideline 19: Pregnant and Breastfeeding Women as Research Participants. International Ethical Guidelines for Health-related Research Involving Humans. 4th ed.Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2016; pp. 71–73. 26. Guideline 25: Conflicts Of Interest. International Ethical Guidelines for Health-related Research Involving Humans. 4th ed.Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2016; pp. 95–98. 27. Na-Bangchang K, Porasuphatana S, Karbwang J: Perspective: repurposed drugs for COVID-19. Arch Med Sci AMS. 2022; 18 (5): 1378–1391. PubMed Abstract | Publisher Full Text | Free Full Text 28. Quincho-Lopez A, Benites-Ibarra CA, Hilario-Gomez MM, et al. : Self-medication practices to prevent or manage COVID-19: A systematic review. PLoS One. 2021; 16 (11): e0259317. PubMed Abstract | Publisher Full Text | Free Full Text 29. Schmith VD, Zhou JJ, Lohmer LRL: The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19. Clin Pharmacol Ther. 2020 Oct; 108 (4): 762–765. PubMed Abstract | Publisher Full Text | Free Full Text 30. Gras M, Gras-Champel V, Moragny J, et al. : Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication. Ann Pharm Fr. 2021 Sep; 79 (5): 522–529. PubMed Abstract | Publisher Full Text | Free Full Text 31. Baracaldo-Santamaría D, Pabón-Londoño S, Rojas-Rodriguez LC: Drug safety of frequently used drugs and substances for self-medication in COVID-19. Ther Adv Drug Saf. 2022; 13 : 204209862210941. PubMed Abstract | Publisher Full Text | Free Full Text 32. Be B, Sa W, Jm B, et al. : Ethical Challenges in Clinical Research During the COVID-19 Pandemic. J Bioethical Inq 2020 Dec [cited 2023 May 30]; 17 (4): 717–722. PubMed Abstract | Publisher Full Text | Free Full Text 33. Burgess T, Rennie S, Moodley K: Key ethical issues encountered during COVID-19 research: a thematic analysis of perspectives from South African research ethics committees. BMC Med Ethics. 2023 Feb 15; 24 (1): 11. PubMed Abstract | Publisher Full Text | Free Full Text 34. Faust A, Sierawska A, Krüger K, et al. : Challenges and proposed solutions in making clinical research on COVID-19 ethical: a status quo analysis across German research ethics committees. BMC Med Ethics. 2021 Jul 19; 22 (1): 96. PubMed Abstract | Publisher Full Text | Free Full Text 35. Lumeng JC, Chavous TM, Lok AS, et al. : Opinion: A risk-benefit framework for human research during the COVID-19 pandemic. Proc Natl Acad Sci U S A. 2020 Nov 10; 117 (45): 27749–27753. PubMed Abstract | Publisher Full Text | Free Full Text 36. Guideline 20: Research in Disasters and Disease Outbreaks. International Ethical Guidelines for Health-related Research Involving Humans. 4th ed.Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2016; pp. 75–78. 37. Kasherman L, Madariaga A, Liu Q, et al. : Ethical frameworks in clinical research processes during COVID-19: a scoping review. BMJ Open. 2021 Jul 23; 11 (7): e047076. PubMed Abstract | Publisher Full Text | Free Full Text 38. Foëx BA: The problem of informed consent in emergency medicine research. Emerg Med J EMJ. 2001 May; 18 (3): 198–204. PubMed Abstract | Publisher Full Text 39. McCarthy MS, McCarthy MW: Ethical challenges of prospective clinical trials during the COVID-19 pandemic. Expert Rev Anti Infect Ther. 2022 Apr; 20 (4): 549–554. PubMed Abstract | Publisher Full Text | Free Full Text 40. Hashmi SK, De Vol E, Hussain F: Pride and Prejudice during the COVID-19 Pandemic: The Misfortune of Inappropriate Clinical Trial Design. J Epidemiol Glob Health. 2021 Mar; 11 (1): 15–19. PubMed Abstract | Publisher Full Text | Free Full Text 41. Branch-Elliman W, Elwy AR, Monach P: Bringing New Meaning to the Term “Adaptive Trial”: Challenges of Conducting Clinical Research During the Coronavirus Disease 2019 Pandemic and Implications for Implementation Science. Open Forum. Infect Dis. 2020 Nov; 7 (11): ofaa490. PubMed Abstract | Publisher Full Text | Free Full Text 42. Stallard N, Hampson L, Benda N, et al. : Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19. Stat Biopharm Res. 2020 Jul 29; 12 (4): 483–497. PubMed Abstract | Publisher Full Text Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 08 Jan 2024 ADD YOUR COMMENT Comment Author details Author details 1 Drug Discovery and Development Center, Thammasat University, Pathum Thani, Bangkok, 12120, Thailand 2 Clinical Coordination and Training Center, Strategic Initiative in Developing Capacity in Ethical Review (SIDCER), Thammasat University, Pathum Thani, 12120, Thailand 3 National Institutes of Health, University of the Philippines Manila, Manila, Metro Manila, 1000, Philippines 4 Clinical Coordination and Training Center, Forum for Ethical Review Committees in Asia and the Pacific (FERCAP), Thammasat University, Pathum Thani, 12120, Thailand 5 Department of Social Sciences, University of the Philippines Manila, Manila, Metro Manila, 1000, Philippines 6 Faculty of Medicine, Khon Kaen University, Nai Mueang, Khon Kaen, 40002, Thailand 7 Department of Pharmacology & Therapeutics, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, 400012, India 8 Department of Community Medicine, PSG Institute of Medical Sciences and Reseach, Coimbatore, 641004, India 9 Forum of Indonesian Recognized Ethics Committees (FIRREC), Jakarta, 10430, Indonesia 10 Dental Research Ethics Committee Faculty of Dentistry, Universitas Indonesia, Jakarta, Jakarta, 10430, Indonesia 11 Health Research Ethics Committee, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia 12 Ethics Committee, Mochtar Riady Institute for Nanotechnology (MRIN), Tangerang, 15810, Indonesia 13 National Institutes of Health, Ministry of Health, Federal Government of Malaysia, Kuala Lumpur, 40170, Malaysia 14 National Ethical Review Board, Nepal Health Research Council, Ministry of Health & Population, Kathmandu, 7626, Nepal 15 Faculty of Medical Science, University of Sri Jayewardenepura, Gangodawila, Nugegoda, 10250, Sri Lanka Juntra Karbwang Roles: Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Validation, Writing – Original Draft Preparation, Writing – Review & Editing Cristina E. Torres Roles: Conceptualization, Investigation, Methodology, Project Administration, Validation, Writing – Review & Editing Arthur M. Navarro Roles: Formal Analysis, Investigation, Software, Validation, Writing – Review & Editing Phanthipha Wongwai Roles: Data Curation, Investigation, Project Administration, Supervision, Validation, Visualization, Writing – Review & Editing Edlyn B. Jimenez Roles: Data Curation, Investigation, Methodology, Supervision, Validation, Writing – Review & Editing Yashashri Shetty Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Sudha Ramalingam Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Paresh Koli Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Lisa Amir Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Septi Dewi Rachmawati Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Monalisa Waworundeng Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Harnawan Rizki Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Asyraf Syahmi Mohd Noor Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Prakash Ghimire Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Pradip Gyanwali Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Subhanshi Sharma Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Namita Ghimire Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Chandanie Wanigatunge Roles: Data Curation, Investigation, Project Administration, Validation, Writing – Review & Editing Kwanchanok Yimtae Roles: Data Curation, Investigation, Project Administration, Supervision, Validation, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information This work was supported by the TDR Strategic Development Fund, the Special Programme for Research and Training in Tropical Diseases co-sponsored by UNICEF, United Nations Development Program, World Bank and World Health Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Article Versions (1) version 1 Published: 08 Jan 2024, 13:19 https://doi.org/10.12688/f1000research.143138.1 Copyright © 2024 Karbwang J et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Karbwang J, Torres CE, Navarro AM et al. The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] . F1000Research 2024, 13 :19 ( https://doi.org/10.12688/f1000research.143138.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 1 VERSION 1 PUBLISHED 08 Jan 2024 Views 0 Cite How to cite this report: Ndebele P. Reviewer Report For: The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] . F1000Research 2024, 13 :19 ( https://doi.org/10.5256/f1000research.156768.r306967 ) The direct URL for this report is: https://f1000research.com/articles/13-19/v1#referee-response-306967 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 19 Aug 2024 Paul Ndebele , The George Washington University, Washington, USA Approved VIEWS 0 https://doi.org/10.5256/f1000research.156768.r306967 The study assessed the readiness of RECs in selected Asian countries in responding to the covid-19 pandemic. 1. The introduction section is outdated. Covid-19 is no longer new and the RECs faced most of these challenges during the early ... Continue reading READ ALL The study assessed the readiness of RECs in selected Asian countries in responding to the covid-19 pandemic. 1. The introduction section is outdated. Covid-19 is no longer new and the RECs faced most of these challenges during the early days of the pandemic. The introduction should be recast to show that the authors were reflecting on the situation in 2020. 2. It is not clear how the respondents were invited. 3. It is not clear how informed consent was obtained. Is the work clearly and accurately presented and does it cite the current literature? Yes Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Partly If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Research ethics I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Ndebele P. Reviewer Report For: The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] . F1000Research 2024, 13 :19 ( https://doi.org/10.5256/f1000research.156768.r306967 ) The direct URL for this report is: https://f1000research.com/articles/13-19/v1#referee-response-306967 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Cave E. Reviewer Report For: The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] . F1000Research 2024, 13 :19 ( https://doi.org/10.5256/f1000research.156768.r298798 ) The direct URL for this report is: https://f1000research.com/articles/13-19/v1#referee-response-298798 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 19 Aug 2024 Emma Cave , Durham Law School, Durham, UK Approved VIEWS 0 https://doi.org/10.5256/f1000research.156768.r298798 This interesting and important paper reports on two connected online surveys across 7 Asian countries in 2021. The research, which was itself subject to research ethics committee (REC) approval in each country, sought to capture the experiences, responses and challenges ... Continue reading READ ALL This interesting and important paper reports on two connected online surveys across 7 Asian countries in 2021. The research, which was itself subject to research ethics committee (REC) approval in each country, sought to capture the experiences, responses and challenges of RECs to COVID-related research protocols across 332 RECs. It offers a range of original insights and is significant in aiding understanding of the state of the REC approvals systems in Asia and of the research challenges that a global public health emergency can bring. The paper demonstrates the importance of RECs being operationally ready to play their important role in upholding ethical standards whilst facilitating scientifically robust and ethical research, and sets out some of the ways this goal can be achieved. The research is useful in planning for future pandemics and also in considering variation and similarities in composition, role and function of RECs across the different countries. Points to consider The survey was carried out in 2021, but in my opinion the article should be updated so that statements made about the current status of the disease are accurate to a 2024 audience. For example, the first two lines stating that the disease is ‘new’ and that there are limited vaccines available is of questionable accuracy in July 2024. The introduction should situate the research in relation to where we are now as well as where we were in 2021 when the survey was conducted. The introduction could usefully say what is novel about COVID from the perspective of ethics committees. This is mentioned on p 11, but the introduction could set out why the authors considered it to be different and therefore worthy of the survey. Was it the nature of the research (eg clinical, public health), the ethical issues it raises of conducting it (eg human challenge trials etc), the proliferation of new guidelines, the importance of timeliness (new expedited review processes), ways of conducting meetings (eg online) etc, or a range of these issues that prompted the research? For a global audience, it would also be useful for the Introduction to give a little more context on the ethics networks (SIDCER) and regulatory system/s across the 7 countries chosen and how consistent they are in approach. What are the key differences between an SR-REC and a NSR-REC? A conclusion is that the networks need to be strengthened so it would be useful to set out the baseline – what was the state of the networks when the survey was conducted? It would be helpful to say something about whether there was overlap in the data captured by the two surveys and how this was taken into account (eg to avoid double counting). Page 5 ‘most members reviewed on scientific/technical issues …and [some] members reviewed only Informed Consent forms’. Could the authors make clearer whether this is about apportionment of work within the ethics committees (eg some members focus on IC and some on technical issues), or a claim that the ethics committees only review technical issues and some only review IC. I thought the point about variation on SOPs was very interesting. Do the authors have a view as to whether standardisation would be beneficial and if so might it be worth commenting in the conclusions? Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Partly If applicable, is the statistical analysis and its interpretation appropriate? I cannot comment. A qualified statistician is required. Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: I am a law academic who has been involved in related research in the UK. I am not an expert in empirical research methods and so the focus of this review is on the presentation of the results rather than its scientific validity. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Cave E. Reviewer Report For: The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] . F1000Research 2024, 13 :19 ( https://doi.org/10.5256/f1000research.156768.r298798 ) The direct URL for this report is: https://f1000research.com/articles/13-19/v1#referee-response-298798 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 08 Jan 2024 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 Version 1 08 Jan 24 read read Emma Cave , Durham Law School, Durham, UK Paul Ndebele , The George Washington University, Washington, USA Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Ndebele P. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 19 Aug 2024 | for Version 1 Paul Ndebele , The George Washington University, Washington, USA 0 Views copyright © 2024 Ndebele P. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The study assessed the readiness of RECs in selected Asian countries in responding to the covid-19 pandemic. 1. The introduction section is outdated. Covid-19 is no longer new and the RECs faced most of these challenges during the early days of the pandemic. The introduction should be recast to show that the authors were reflecting on the situation in 2020. 2. It is not clear how the respondents were invited. 3. It is not clear how informed consent was obtained. Is the work clearly and accurately presented and does it cite the current literature? Yes Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Partly If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Research ethics I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Ndebele P. Peer Review Report For: The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] . F1000Research 2024, 13 :19 ( https://doi.org/10.5256/f1000research.156768.r306967) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-19/v1#referee-response-306967 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Cave E. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 19 Aug 2024 | for Version 1 Emma Cave , Durham Law School, Durham, UK 0 Views copyright © 2024 Cave E. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions This interesting and important paper reports on two connected online surveys across 7 Asian countries in 2021. The research, which was itself subject to research ethics committee (REC) approval in each country, sought to capture the experiences, responses and challenges of RECs to COVID-related research protocols across 332 RECs. It offers a range of original insights and is significant in aiding understanding of the state of the REC approvals systems in Asia and of the research challenges that a global public health emergency can bring. The paper demonstrates the importance of RECs being operationally ready to play their important role in upholding ethical standards whilst facilitating scientifically robust and ethical research, and sets out some of the ways this goal can be achieved. The research is useful in planning for future pandemics and also in considering variation and similarities in composition, role and function of RECs across the different countries. Points to consider The survey was carried out in 2021, but in my opinion the article should be updated so that statements made about the current status of the disease are accurate to a 2024 audience. For example, the first two lines stating that the disease is ‘new’ and that there are limited vaccines available is of questionable accuracy in July 2024. The introduction should situate the research in relation to where we are now as well as where we were in 2021 when the survey was conducted. The introduction could usefully say what is novel about COVID from the perspective of ethics committees. This is mentioned on p 11, but the introduction could set out why the authors considered it to be different and therefore worthy of the survey. Was it the nature of the research (eg clinical, public health), the ethical issues it raises of conducting it (eg human challenge trials etc), the proliferation of new guidelines, the importance of timeliness (new expedited review processes), ways of conducting meetings (eg online) etc, or a range of these issues that prompted the research? For a global audience, it would also be useful for the Introduction to give a little more context on the ethics networks (SIDCER) and regulatory system/s across the 7 countries chosen and how consistent they are in approach. What are the key differences between an SR-REC and a NSR-REC? A conclusion is that the networks need to be strengthened so it would be useful to set out the baseline – what was the state of the networks when the survey was conducted? It would be helpful to say something about whether there was overlap in the data captured by the two surveys and how this was taken into account (eg to avoid double counting). Page 5 ‘most members reviewed on scientific/technical issues …and [some] members reviewed only Informed Consent forms’. Could the authors make clearer whether this is about apportionment of work within the ethics committees (eg some members focus on IC and some on technical issues), or a claim that the ethics committees only review technical issues and some only review IC. I thought the point about variation on SOPs was very interesting. Do the authors have a view as to whether standardisation would be beneficial and if so might it be worth commenting in the conclusions? Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Partly If applicable, is the statistical analysis and its interpretation appropriate? I cannot comment. A qualified statistician is required. Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise I am a law academic who has been involved in related research in the UK. I am not an expert in empirical research methods and so the focus of this review is on the presentation of the results rather than its scientific validity. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Cave E. Peer Review Report For: The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey [version 1; peer review: 2 approved] . F1000Research 2024, 13 :19 ( https://doi.org/10.5256/f1000research.156768.r298798) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-19/v1#referee-response-298798 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "The readiness of the Asian research ethics...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/13-19/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/13-19/v1&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/13-19/v1" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Karbwang J et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/13-19/v1/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/13-19", templates : { twitter : "The readiness of the Asian research ethics committees in responding.... Karbwang J et al., published by " + "@F1000Research" + ", https://f1000research.com/articles/13-19/v1" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/143138/156768") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "156768"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "270724": 0, "292740": 0, "270725": 0, "270726": 0, "270727": 0, "292736": 0, "292737": 0, "292738": 0, "270723": 0, "292739": 0, "270732": 0, "270728": 0, "270729": 0, "270730": 0, "270731": 0, "306964": 0, "306965": 0, "289301": 0, "306966": 0, "289302": 0, "289303": 0, "306967": 9, "306963": 0, "289308": 0, "289309": 0, "289310": 0, "289304": 0, "306968": 0, "289305": 0, "289306": 0, "289307": 0, "298797": 0, "298798": 12, "298799": 0, "298800": 0, "251107": 0, "251108": 0, "277868": 0, "277869": 0, "277870": 0, "277871": 0, "277866": 0, "277867": 0, "277872": 0, "277873": 0, "277874": 0, "277875": 0, "292732": 0, "292733": 0, "292734": 0, "292735": 0, "292731": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "0072ab8b-ff86-48d7-aad4-08fd3732ec6f"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "[email protected]", infoEmail: "[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });